about
Diethylcarbamazine (DEC)-medicated salt for community-based control of lymphatic filariasisEpidemiology of plasmodium-helminth co-infection in Africa: populations at risk, potential impact on anemia, and prospects for combining controlRecombinant antigen-based antibody assays for the diagnosis and surveillance of lymphatic filariasis - a multicenter trialLymphatic Filariasis (Elephantiasis) Elimination: A public health success and development opportunity.Longitudinal monitoring of the development of antifilarial antibodies and acquisition of Wuchereria bancrofti in a highly endemic area of HaitiProgress and impact of 13 years of the global programme to eliminate lymphatic filariasis on reducing the burden of filarial diseaseCloning and expression of a 12 kDa serospecific epitope of Wuchereria bancrofti.Using knowledge, attitudes and practice (KAP) surveys on lymphatic filariasis to prepare a health promotion campaign for mass drug administration in Alor District, Indonesia.A case study of risk factors for lymphatic filariasis in the Republic of Congo.Lymphatic filariasis: a method to identify subclinical lower limb change in PNG adolescents.The impact of mass drug administration and long-lasting insecticidal net distribution on Wuchereria bancrofti infection in humans and mosquitoes: an observational study in northern Uganda.Filariasis in an infant with B-cell acute lymphoblastic leukemia: a rare enigma.Immunomodulation by filarial nematodes.Understanding the community impact of lymphatic filariasis: a review of the sociocultural literature.Clinical and pathological aspects of filarial lymphedema and its management.Neglected tropical diseases in Uganda: the prospect and challenge of integrated control.Prospects for the control of neglected tropical diseases by mass drug administration.Lymphatic filariasis in children: clinical features, infection burdens and future prospects for elimination.An investigation of the disparity in estimates of microfilaraemia and antigenaemia in lymphatic filariasis surveys.Impact of vectorborne parasitic neglected tropical diseases on child health.Rapid assessment of the geographical distribution of lymphatic filariasis in Uganda, by screening of schoolchildren for circulating filarial antigens.Global trends in neglected tropical disease control and elimination: impact on child health.Lymphatic filariasis among children and adolescents: spatial identification via socio-environmental indicators to define priority areas for elimination.Evaluation of diagnostic tests for Wuchereria bancrofti infection in Brazilian schoolchildren.A qualitative study of the perceptions, practices and socio-psychological suffering related to chronic brugian filariasis in Kerala, southern India.Plasmodium knowlesi and Wuchereria bancrofti: Their Vectors and Challenges for the Future.Urban lymphatic filariasis in central Nigeria.Lymphatic filariasis elimination efforts in Rufiji, southeastern Tanzania: decline in circulating filarial antigen prevalence in young school children after twelve rounds of mass drug administration and utilization of long-lasting insecticide-treateThe rationale and cost-effectiveness of a confirmatory mapping tool for lymphatic filariasis: Examples from Ethiopia and Tanzania.Survey of Bancroftian filariasis infection in humans and Culex mosquitoes in the western Brazilian Amazon region: implications for transmission and control.Efficacy of co-administration of albendazole and diethylcarbamazine against geohelminthiases: a study from South India.Molecular xenomonitoring (MX) and transmission assessment survey (TAS) of lymphatic filariasis elimination in two villages, Menoufyia Governorate, Egypt.The influence of the mass administration of diethylcarbamazine, alone or with albendazole, on the prevalence of filarial antigenaemia.Antifilarial drugs, in the doses employed in mass drug administrations by the Global Programme to Eliminate Lymphatic Filariasis, reverse lymphatic pathology in children with Brugia malayi infection.Children and adolescents infected with Wuchereria bancrofti in Greater Recife, Brazil: a randomized, year-long clinical trial of single treatments with diethylcarbamazine or diethylcarbamazine-albendazole.Development and evaluation of a rapid flow-through immuno filtration test using recombinant filarial antigen for diagnosis of brugian and bancroftian filariasis.Field validation of sensitivity and specificity of rapid test for detection of Brugia malayi infection.Identifying residual transmission of lymphatic filariasis after mass drug administration: Comparing school-based versus community-based surveillance - American Samoa, 2016Towards elimination of lymphatic filariasis in southeastern Madagascar: Successes and challenges for interrupting transmission
P2860
Q24243051-A44BECC5-31CE-47D6-BEE8-809C8605193DQ24656072-749C6E3E-9585-4E66-BD00-A29FA5C2CBA5Q24795014-76693F04-DCE0-4AE1-B555-833D60D77A30Q24801002-D2828B6E-262A-439C-BAA4-690A60B9D555Q28484230-2FD36B1A-9D91-46A7-BAA2-93BA5A9C91ACQ28545108-DB0C72AC-28B5-4048-91D4-F4766654A3A2Q33223646-681D629B-5E13-42A0-9C4C-6796E7DAE62FQ33261019-A24AD883-C37F-40B9-8778-5A380D3BC9BFQ33874155-091E319C-48A9-4F40-B976-2D17E839D4A4Q35115525-744B13DA-ED5C-4DF5-9CDB-58355E8E0F94Q35172053-402DC100-8837-4726-9995-EAD0791BBA36Q35772396-37206D06-4F59-4E5B-B3F9-972DC8552B18Q36265018-9C1CC2F6-296A-4BFD-A3C6-C2F7A29BA77AQ36885887-0432964B-9C51-4204-924C-A2E4A10F04CAQ36908766-216BB931-492E-4995-8887-2BD4E5745893Q36934562-583E367C-6C8C-428E-BC71-0F6834E654A2Q37557676-4E52236D-4F5C-4DDF-A2D4-5457FDA950D9Q37910336-72F71BB3-C919-434D-AA24-D21A518F3C50Q38535058-0278031A-4C96-4E0C-96C5-990286D8F9F1Q38752545-386D0F7A-FC37-4B0B-80FD-D25034724BAAQ38881064-4D8D9A46-347A-4730-A1F2-23F433CF1CE7Q38894845-F7152096-7721-430B-BEAD-20F6C4156E40Q38919837-F352A05B-635E-4870-B52E-750E83075EE1Q39322274-21FB665C-EA6B-4747-A2EA-AE3D628FCA81Q39497707-42880138-8D39-40A1-9ACE-B30EEE57BF89Q39566529-88A6B6EC-A215-41FA-B503-E03BFA199224Q39746445-9CC42D51-B2E5-434E-ACEA-11EF86DED29EQ40204964-6F9000B3-A3F8-4C33-9568-CD21CBA46EA8Q42695850-F499BF47-AF45-4921-810A-C0C4DC1F6D94Q43359451-59009A1B-B90F-4F52-811C-09A7ACF697E0Q44006273-54E29AED-D661-4888-A2BE-D6E2C0DF30C2Q44163504-275F55D5-FA52-4A1D-B656-A4E6F6B889CCQ44191478-908C054D-7DA9-40F7-A87F-EB9085A6A30EQ46063960-A4201E21-A43A-4B92-BF94-EB270929A36AQ46156819-43F08D23-9633-42D3-A06E-358E2B5C48A2Q50768879-CD09677D-8021-4208-A198-706A2362A8F9Q51552695-31BEA764-8433-46AD-869D-D7BDD198C9D9Q56363362-DDC0092F-27DA-4576-BC4D-C927F2E1F030Q57929144-D25C2E8F-D341-4F21-9DEE-1B5354CD33FD
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Lymphatic filariasis: an infection of childhood.
@ast
Lymphatic filariasis: an infection of childhood.
@en
Lymphatic filariasis: an infection of childhood.
@nl
type
label
Lymphatic filariasis: an infection of childhood.
@ast
Lymphatic filariasis: an infection of childhood.
@en
Lymphatic filariasis: an infection of childhood.
@nl
prefLabel
Lymphatic filariasis: an infection of childhood.
@ast
Lymphatic filariasis: an infection of childhood.
@en
Lymphatic filariasis: an infection of childhood.
@nl
P2860
P1476
Lymphatic filariasis: an infection of childhood.
@en
P2093
P2860
P304
P356
10.1046/J.1365-3156.2001.00765.X
P577
2001-08-01T00:00:00Z